pargyline   Click here for help

GtoPdb Ligand ID: 7262

Synonyms: A-19120 | Eutonyl® | MO-911
Approved drug
pargyline is an approved drug
Compound class: Synthetic organic
Comment: Pargyline is a monoamine oxidase inhibitor (MAOI).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 3.24
Molecular weight 159.1
XLogP 2.04
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(Cc1ccccc1)CC#C
Isomeric SMILES CN(Cc1ccccc1)CC#C
InChI InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3
InChI Key DPWPWRLQFGFJFI-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Used to treat hypertension. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
By inhibiting monoamine oxidase (MAO), this drug increases the levels of serotonin and catecholamine neurotransmitters (epinephrine, norepinephrine, and dopamine) in synaptic storage granules throughout the central and sympathetic nervous systems. This action suppresses sympathetic activity, including heart rate and blood pressure. See the DrugBank link for further details.